Abstract
Skin diseases continue to affect human health and cause a significant disease burden on the healthcare system.We aimed to report the changing trends in the burden of skin disease in China from 1990 to 2019, Which has an important role in develo** targeted prevention strategies. We applied Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2019 analytical tools to calculate the age-standardized Prevalence and Incidence in 2019, number of years lived with disability (YLDs) and age-standardized YLDs from 1990 to 2019 of skin and subcutaneous diseases, notifiable infectious skin diseases and skin tumors in China. Among the skin and subcutaneous diseases in China in 2019, dermatitis contributed to the greatest YLD (2.17 million, 95% uncertainty interval[UI]: 1.28–3.36). Age-standardized YLD rates for leprosy decreased from 0.09 (95%UI: 0.06–0.13) in 1990 to 0.04 (95%UI: 0.03–0.06) in 2019; the proportional decrease was 55.56% over 30 years. Age-standardized YLDs for HIV and sexually transmitted infections increased by 26% during the same time period. Age-standardized YLDs for non-melanoma skin cancer increased at a much higher rate than melanoma between 1990 and 2019. Dermatitis and scabies continue to have an important role in the burden of skin and subcutaneous disease burden in China. The burden of non-melanoma cell cancer has increased most significantly over the past three decades.
Similar content being viewed by others
Data availability
The data sets used and/or analysed during the current study are available from the corresponding author upon reasonable request.
References
World Health Organization Epidemiology and management of common skin diseases in children in develo** countries (Internet). https://iris.who.int/handle/10665/69229
Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA, Wulf SK, Michaud C, Murray JL, Naghavi C M (2014) The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 134(6):1527–1534
Wu JH, Cohen BA (2019) The stigma of skin disease. Curr Opin Pediatr 31(4):509–514
Laughter MR, Maymone MBC, Karimkhani C, Rundle C, Hu S, Wolfe S, Abuabara K, Hollingsworth P, Weintraub GS, Dunnick CA, Kisa A, Damiani G, Sheikh A, Singh JA, Fukumoto T, Desai R, Grada A, Filip I, Radfar A, Naghavi M, Dellavalle RP (2020) The Burden of skin and Subcutaneous diseases in the United States from 1990 to 2017. JAMA Dermatol 156(8):874–881
Kavita A, Thakur JS, Narang T (2023) The burden of skin diseases in India: global burden of Disease Study 2017. Indian J Dermatol Venereol Leprol 89(3):421–425
Dong W, An J, Geng P, Zeng X, Chen Y, Zhao Z, Zhou M (2020) Years lost due to disability from skin diseases in China 1990–2017: findings from the global burden of Disease Study 2017. Br J Dermatol 182(1):248–250
Peng D, Sun J, Wang J, Qi X, Li G (2021) Burden of skin disease - China, 1990–2019. China CDC Wkly 3(22):472–475
GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1204–1222
Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S (2015) Disability weights for the global burden of Disease 2013 study. Lancet Glob Health 3(11):e712–e723
Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM (2021) The global burden of atopic dermatitis: lessons from the global burden of Disease Study 1990–2017. Br J Dermatol 184(2):304–309
Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345–360
Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI (2009) Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 124(6):1251–8e23
Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM (2018) The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 73(3):696–704
Sunderkötter C, Wohlrab J, Hamm H (2021) Scabies: epidemiology, diagnosis, and treatment. Dtsch Arztebl Int 118(41):695–704
Seidelman J, Garza RM, Smith CM, Fowler VG Jr (2017) More than a Mite Contagious: Crusted Scabies. Am J Med 130(9):1042–1044
Cassell JA, Middleton J, Nalabanda A, Lanza S, Head MG, Bostock J, Hewitt K, Jones CI, Darley C, Karir S, Walker SL (2018) Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 18(8):894–902
Zhang W, Zhang Y, Luo L, Huang W, Shen X, Dong X, Zeng W, Lu H (2020) Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017. Emerg Microbes Infect 9(1):813–816
World Health Organization Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives (Internet). https://www.who.int/publications/i/item/who-wer9536
Vieira MCA, Nery JS, Paixão ES, Freitas de Andrade KV, Oliveira Penna G, Teixeira MG (2018) Leprosy in children under 15 years of age in Brazil: a systematic review of the literature. PLoS Negl Trop Dis 12(10):e0006788
Dharmawan Y, Fuady A, Korfage I, Richardus JH (2021) Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis 15(8):e0009651
Peiwen S, Wang Le, Wang Hongsheng, Liangbin Yan, Meiwen Yu (2023) Epidemiological characteristics of leprosy in China from 2016 to 2020. Chin J Dermatol 56(3):204–209
Chu T, Liu D, Huai P, Chen X, Han S, Chen S, Zhang F (2020) Comprehensive measures succeeded in improving early detection of leprosy cases in post-elimination era: experience from Shandong province, China. PLoS Negl Trop Dis 14(2):e0007891
Zheng Y, Yu Q, Lin Y, Zhou Y, Lan L, Yang S, Wu J (2022) Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis 22(4):541–551
Taylor MM, Frasure-Williams J, Burnett P, Park IU (2016) Interventions to improve sexually transmitted Disease Screening in Clinic-based settings. Sex Transm Dis 43(2 Suppl 1):S28–S41
Rietmeijer CA Improving care for sexually transmitted infections (2019). J Int AIDS Soc 22 Suppl 6 (Suppl Suppl 6):e25349
World Health Organization Report on global sexually transmitted infection surveillance 2018 (Internet). https://www.who.int/reproductivehealth/publications/stissurveillance-2018/en/
World Health Organization Global health sector strategy on sexually transmitted infections 2016–2021 (Internet). https://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/
Leigh IM (2014) Progress in skin cancer: the U.K. experience. Br J Dermatol 171(3):443–445
Hu W, Fang L, Ni R, Zhang H, Pan G (2022) Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer 22(1):836
Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 29(3):160–169
Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A (2017) The Burden of Primary Liver Cancer and underlying etiologies from 1990 to 2015 at the Global, Regional, and National Level: results from the global burden of Disease Study 2015. JAMA Oncol 3(12):1683–1691
Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, Bernabei R, Peris K (2017) Skin Cancer epidemics in the Elderly as an emerging issue in geriatric oncology. Aging Dis 8(5):643–661
Funding
None.
Author information
Authors and Affiliations
Contributions
Conceptualization: YK and PH; Data curation: YK and PX; Formal analysis: YK and PX; Methodology: YK; Project administration: PH and FZ; Supervision: PH and FZ; Validation: PX, PH and FZ; Visualization: PH and FZ; Writing-original draft: YK; Writing-review &editing: YK, PX, PH and FZ.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors declare that ther have no conflict of interest to disclose.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kong, Y., **ng, P., Huai, P. et al. The burden of skin diseases in China: global burden of Disease Study 2019. Arch Dermatol Res 316, 277 (2024). https://doi.org/10.1007/s00403-024-03046-5
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00403-024-03046-5